Filing Details
- Accession Number:
- 0001576280-23-000199
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-04 18:25:38
- Reporting Period:
- 2023-12-01
- Accepted Time:
- 2023-12-04 18:25:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576280 | Guardant Health Inc. | GH | Services-Medical Laboratories (8071) | 454139254 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1927831 | Kumud Kalia | 3100 Hanover Street Palo Alto CA 94304 | Chief Information Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-12-01 | 710 | $0.00 | 12,079 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-12-01 | 353 | $26.33 | 11,726 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2023-12-01 | 5,800 | $26.37 | 5,926 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | RESTRICTED STOCK UNITS | Disposition | 2023-12-01 | 710 | $0.00 | 710 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,972 | No | 4 | M | Direct |
Footnotes
- These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.36 to $26.395 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter.
- Not applicable for Restricted Stock Units.
Billionaire Hedge Funds
